Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery

Autor: Yunes, Michael J.¹, Neuschatz, Andrew C.¹, Bornstein, Linda E.², Naber, Stephen P.³, Band, Vimla¹, Wazer, David E.^1,4 dwazer@lifespan.org

Publikováno v: International Journal of Radiation Oncology, Biology, Physics. Jul2003, Vol. 56 Issue 3, p653-657. 5p.

The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.

Autor: Neuschatz, Andrew C., DiPetrillo, Thomas, Steinhoff, Margaret, Safaii, Homa, Yunes, Michael, Landa, Marcia, Chung, Maureen, Cady, Blake, Wazer, David E.

Publikováno v: Cancer (0008543X); Apr2002, Vol. 94 Issue 7, p1917-1924, 8p

Tumor bed boost omission after negative re-excision in breast-conservation treatment.

Autor: Arthur DW; Deparment of Radiation Oncology, Virginia Commonwealth University, Medical College of Virginia Campus, 401 College Street, Box 58, Richmond, Virginia 23298, USA. darthur@mcvh-vcu.edu, Cuttino LW, Neuschatz AC, Koo DT, Morris MM, Bear HD, Kaplan BJ, Dawson K, Wazer DE

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2006 Jun; Vol. 13 (6), pp. 794-801. Date of Electronic Publication: 2006 Apr 14.